4 Waldenstrom Macroglobulinemia Clinical Trials in Boston, MA (2026)

Q: How do I join a clinical trial in Boston?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you.

Recruiting Waldenstrom Macroglobulinemia Studies in Boston

NCT07275021Recruiting

Cerebral/ Cortical Visual Impairment: Screening, Identification and Outcome Prediction in Neonates

Cerebral/Cortical Visual Impairment (CVI) is the leading cause of childhood visual impairment in the United States and other industrialized countries. CVI is a brain-based visual disorder in which vis...

Boston, MA60 participantsBrigham and Women's Hospital

View Study Details

NCT06561347Recruiting

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

The purpose of this study is to determine the very good partial response (VGPR) or better rate in participants with Waldenström macroglobulinemia (WM). The names of the study drugs involved in this s...

Boston, MAPHASE256 participantsMassachusetts General Hospital

View Study Details

NCT07231952Recruiting

A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

The purpose of this study is to find out if the combination of pirtobrutinib, venetoclax, and rituximab is an effective treatment for participants with Waldenström's macroglobulinemia (WM)/lymphoplasm...

Boston, MAPHASE240 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT06510491Recruiting

Epcoritamab in Previously Treated WM

This study is being done to determine if epcoritamab can be used to treat participants with previously treated Waldenstrom Macroglobulinemia (WM). The names of the study drug involved in this study i...

Boston, MAPHASE220 participantsGottfried von Keudell, MD PhD

View Study Details

About Waldenstrom Macroglobulinemia Clinical Trials in Boston

Waldenstrom macroglobulinemia is a rare type of non-Hodgkin lymphoma where cancer cells produce large amounts of an abnormal protein called macroglobulin. It progresses slowly and may not require immediate treatment. Options include targeted therapy, chemotherapy, and plasmapheresis.

There are currently 4 waldenstrom macroglobulinemia clinical trials recruiting participants in Boston, MA. These studies are seeking a combined 176 participants. Research is being sponsored by Brigham and Women's Hospital, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Waldenstrom Macroglobulinemia Clinical Trials in Boston — FAQ

Are there waldenstrom macroglobulinemia clinical trials in Boston?

Yes, there are 4 waldenstrom macroglobulinemia clinical trials currently recruiting in Boston, MA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Boston?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boston research site will contact you about next steps.

Are clinical trials in Boston free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boston studies also compensate for your time and travel.

What waldenstrom macroglobulinemia treatments are being tested?

The 4 active trials in Boston are testing new therapies including novel drugs, biologics, and treatment approaches for waldenstrom macroglobulinemia.

Data updated July 19, 2026 from ClinicalTrials.gov